Penrose

Name

Penrose

Legal name

Scope Health

Website

https://penrose.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Scope Health builds AI-powered clinical documentation (Scribe) and AI voice agents (Access) for healthcare providers, serving individual clinicians via self-serve and health systems via enterprise contracts.

Ownership category

akta.pro rank

Product category

Healthcare AI / Clinical Documentation Software

NAICS

Software Publishers (513210)

SIC

Services-Prepackaged Software (7372), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Nursing, Clinical Notes & Documentation Workflow Tools (HLACAAAG)

akta.pro secondary industries

Patient Intake, Digital Registration & eForms (HLACAEAF), Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH)

Keywords

• Clinical AI documentation
• Healthcare voice agents
• Ambient medical scribe
• Patient access automation
• Clinical workflow software

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Scribe Subscription: SaaS subscription model for AI-powered clinical documentation targeting individual clinicians and healthcare practices.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels2 records

Core offering

Penrose sells two AI-powered healthcare software products. Scribe is an AI clinical documentation tool that enables clinicians to chart faster and more accurately, reducing administrative burden and burnout. Access is a set of AI voice agents that practices and health systems deploy to cut patient wait times and ease capacity bottlenecks by automating patient intake, scheduling, and routing to the appropriate provider.

Differentiator

Problem solved

Functional benefit

Brands

• Scribe: AI-powered notes for clinicians that enables faster and more accurate charting to reduce burnout.
• Access

Products and services

• Scribe Scribe is an AI-powered clinical documentation tool that enables clinicians to chart faster and more accurately. It automates medical note generation from clinician input to reduce administrative burden and burnout, and is offered as a self-serve sign-up SaaS targeting individual clinicians and small practices.
• Access Access is a set of AI voice agents deployed by practices and health systems to cut patient wait times and ease capacity bottlenecks. It automates patient intake, appointment scheduling, and intelligent routing to the appropriate provider, and is sold via enterprise/quote-based sales motions to health systems.

Quantifiable outcome

• Cardiology patient wait time: 2 months; Oncology wait time: 6 weeks; Orthopedics wait time: 5 weeks

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature2 records

Partnerships

One partnership is on record.

• University of Miami Health SystemcoreStrategic or Co-development PartnerMajor academic medical center partnership featured on company website as a key partner. University of Miami Health System represents a flagship customer and development partner for clinical AI solutions.

Scale indicators1 record

Emerging players

• Notable: AI-powered patient intake and administrative workflow automation for health systems. Overlaps with Scope Health's Access voice agent product on patient access and routing automation.
• Ambience Healthcare: AI operating system for healthcare including ambient documentation and coding. Comparable in product scope (documentation + revenue cycle) and enterprise health system GTM, with significant venture backing.

Others

• Iodine Software: Enterprise AI for healthcare operations including clinical documentation improvement. Adjacent competitor in the broader AI-clinical workflow category serving health systems.

Broad incumbents

• Commure: Healthcare AI platform backed by General Catalyst offering ambient documentation, patient engagement, and revenue cycle solutions. Directly comparable dual-product strategy (documentation + access/operations) and shares an investor with Scope Health.
• athenahealth: Major EHR and practice management platform with embedded AI documentation and patient engagement capabilities. Represents the platform incumbent threat that could bundle AI documentation natively.
• Microsoft Nuance DAX: Microsoft-owned ambient clinical intelligence solution with deep Epic and large health system penetration. The dominant incumbent in AI clinical documentation, representing both the primary competitive threat and a likely exit/roll-up target for the category.

Direct peers

• Suki AI: AI voice assistant for clinicians that generates clinical notes and documentation directly comparable to Scope Health's Scribe module. Targets the same clinician burnout and administrative burden pain points.
• DeepScribe: AI medical scribe that captures patient-provider conversations and generates clinical documentation. Direct competitor in the ambient clinical documentation category with similar specialty practice focus.
• Abridge: AI-powered clinical documentation and ambient scribe platform targeting clinicians and health systems. Most direct competitor to Scope Health's Scribe product, with overlapping value proposition of reducing documentation burden and clinician burnout.
• Augmedix: Ambient AI documentation platform serving health systems and clinicians with automated medical note generation. Comparable product offering and GTM motion targeting large provider organizations.

Market position

Customer concentration

• LinkedInlinkedin.com/company/penrose-ai

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Penrose